# A Prospective, Observational Study of Patients With Cervical Dystonia (Dystonie) Treated With OnabotulinumtoxinA

> **NCT01655862** · — · COMPLETED · sponsor: **Allergan** · enrollment: 62 (actual)

## Conditions studied

- Torticollis

## Interventions

- **BIOLOGICAL:** OnabotulinumtoxinA

## Key facts

- **NCT ID:** NCT01655862
- **Lead sponsor:** Allergan
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-07
- **Primary completion:** 2017-02
- **Final completion:** 2017-02
- **Target enrollment:** 62 (ACTUAL)
- **Last updated:** 2017-03-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01655862

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01655862, "A Prospective, Observational Study of Patients With Cervical Dystonia (Dystonie) Treated With OnabotulinumtoxinA". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01655862. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*